18 January 2017

Publication of Circular

RNS Number : 4091U Verona Pharma PLC 18 January 2017

Read more

11 January 2017

Holding(s) in Company

RNS Number : 8462T Verona Pharma PLC 11 January 2017

Read more

4 January 2017

Holding(s) in Company

Read more

Targeting unmet needs

384m people worldwide suffer from COPD and 37 years is the median life expectancy of CF patients

Read more about COPD and CF in the unmet needs section of this website

Go

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us